Skip to main content

ORIGINAL RESEARCH article

Front. Psychiatry, 03 December 2020
Sec. Mood Disorders
This article is part of the Research Topic Impact of the Coronavirus Pandemic (COVID-19) on Mood Disorders and Suicide View all 41 articles

Tele-Psychiatry Assessment of Post-traumatic Stress Symptoms in 100 Patients With Bipolar Disorder During the COVID-19 Pandemic Social-Distancing Measures in Italy

  • Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy

The acute phase of the COrona VIrus Disease-19 (COVID-19) emergency determined relevant stressful burdens in psychiatric patients, particularly those with chronic mental disorders such as bipolar disorder (BD), not only for the threat of being infected but also for the strict lock-down and social-distancing measures adopted, the economic uncertainty, and the limited possibilities to access psychiatric services. In this regard, telepsychiatry services represented a new important instrument that clinicians could adopt to monitor and support their patients. The aim of the present study was to investigate acute post-traumatic stress symptoms (PTSS) reported by patients with BD followed in the framework of a telepsychiatry service, set up in the acute phase of the COVID-19 outbreak at the psychiatric clinic of the University of Pisa (Italy). A sample of 100 patients were consecutively enrolled and assessed by the IES-r, GAD-7, HAM-D, and YMRS. Patients reported a mean (±SD) IES-r total score of 18.15 ± 13.67. Further, 17% of the sample reported PTSS (IES-r > 32), 17% depressive symptoms (HAM-D > 17), and 26% anxiety symptoms (GAD-7 > 10). Work and financial difficulties related to the COVID-19 pandemic and anxiety symptoms appeared to be positively associated with the development of acute PTSS. Acute manic symptoms appeared to be protective. The data of the present study suggest the relevance of monitoring patients with BD exposed to the burden related to the COVID-19 outbreak for prompt assessment and treatment of PTSS.

Introduction

Increasing literature suggests how COVID-19 and the related quarantine or social-distancing measures, adopted in the acute phase, may have represented a traumatic experience that could have affected mental health and well-being of exposed individuals (1, 2). At the end of April 2020, after 55 days of national lock-down during the so-called first phase of the pandemic, in Italy the number of COVID-19 cases exceeded 200,000 units and the death count 31,000 units. During this period, most of the population lived in home-confinement environments avoiding social interactions, and the COVID-19 outbreak may have represented a relevant trauma not only for the risk of being infected but also for the strict lock-down and social-distancing measures, the economic uncertainty, and the limited possibilities to access mental health services. The first studies investigating mental health stress burden on a general population exposed to the COVID-19 pandemic showed high levels of depression, anxiety, and post-traumatic stress symptoms (PTSS) (37). Particularly, Liu et al. (5) reported a 7% prevalence rate of clinically significant PTSS in the Chinese general population living in the hardest-hit areas during the COVID-19 epidemic. Another recent study showed post-traumatic stress disorder (PTSD) and depression rates of 2.7 and 9.0%, respectively, among 2,485 home-quarantined Chinese University students (6).

Despite the fact that psychological burden of the COVID-19 emergency has been very different across different countries and strongly related to specific regional conditions (5, 8), it seems very likely that the pandemic will affect long-term mental health in populations with low degree of resilience, such as patients with chronic psychiatric disorders such as bipolar disorder (BD). Comorbidity between BD and PTSD has been widely investigated in the literature, showing prevalence rates ranging between 4 and 40% for PTSS, and between 9 and 20% for PTSD diagnosis (9, 10).

As the general population, subjects affected by pre-existing mental disorders faced several stressors during the period of national lockdown in Italy, such as isolation, loneliness, sudden bereavement without being able to bury their loved ones, and fear of ultimately and suddenly losing their own lives (11). Despite the fact that some authors did not find any detrimental effect of the COVID-19 outbreak on the social inclusion and well-being in subjects with mental health problems (12), pandemic concerns might have represented a significant stressor, particularly for subjects with severe mental illness, which were vulnerable to the risk of anxiety and mood relapse (13). Further, social distancing limited access to treatment and support centers, including mental health services, day programs, and congregate care settings, as well as limiting contact with families and loved ones, enduring increasingly prohibitive visitor policies (1316). On one hand, some individuals with severe mental disorders might have been less impacted by the public health restrictions, because they lived already “socially distanced,” with minimal interpersonal contacts outside of their immediate living environment and necessities, whether as a result of their symptoms, societal marginalization, or personal choice; on the other hand, in most of these patients the lockdown measures further reduced and collapsed the weak existing social networks (17). Consistently, Hao et al. (11) reported more severe acute PTSS, anxiety, and depression symptoms among Chinese psychiatric patients during the peak of the COVID-19 epidemic with strict lockdown measures than in healthy controls, with more than one-quarter of patients reporting PTSS.

A major issue for clinicians and researchers in psychiatry is now to detect which impact the COVID-19 pandemic will have on psychiatric long-term care going forward. The sudden changes occurred could have significantly impacted psychiatric patients' mental health as well as having reduced their opportunity to access psychiatric services (13, 16). Because of the pandemic, psychiatric inpatients were exposed to a high risk of COVID-19 infection. Consequently, most of the psychiatric patients in maintenance phase or with minor symptoms received their treatment at home to reduce the risk of infection, and clinicians first adopted telepsychiatry services to monitor their patients (13, 18, 19). Further, a significant portion of psychiatric patients that were quarantined in their homes resulted in social isolation and loneliness, which could fuel anxiety and mood destabilization secondary to physical distancing and shelter-in-place guidelines. Therefore, connecting with these individuals seemed essential to provide treatment for acute psychiatric concerns as well as to continue treatment of chronic illness. Nowadays, a rich literature supports telepsychiatry, demonstrating excellent acceptance and non-inferior outcomes across ages, conditions, cultures, and languages (20). Remote consultation via telemedicine to overcome the rules of social distancing during the peak of the COVID-19 pandemic had been rapidly embraced in several countries (8, 2123) and operational instructions for mental health departments and community hospitals, such as tele-health and phone check-ins, had been also promptly set up in some hospitals in Italy, including the psychiatric clinic of the University of Pisa, during the acute phase of the pandemic (24, 25).

To date there is still a lack of data on the impact of COVID-19 pandemic on psychiatric patients, particularly on those affected by BD. The aim of the present study was to examine the psychopathological impact experienced by BD patients assessed in a telepsychiatry setting displaced during the peak of the COVID-19 epidemic and the strict lockdown and social-distancing measures in a major University hospital in central Italy (Pisa). In particular, we focused on the investigation of PTSS developed in response to the COVID-19 emergency and on the possible factors associated with them.

Methods

Study Sample and Procedures

The present cross-sectional study included a consecutive sample of 100 subjects with a DSM-5 diagnosis of BD enrolled at the adult outpatient psychiatric service of the Azienda Ospedaliera Universitaria Pisana (AOUP, Pisa, Italy) while followed in the framework of a telepsychiatry service, set up during the acute phase of the COVID-19 pandemic. This specific service was introduced from 1 March 2020 to carry on the psychiatric care of BD patients followed at the AOUP, during the lockdown phase of the COVID-19 emergency. Patients with a manic episode, severe depression, catatonia, active alcohol or substance abuse, or cognitive impairment were excluded from the tele-psychiatric service. Patients were contacted once a week by an expert psychiatric clinician (BB, BFM, CA, and MA) for psychiatric control visits. The study enrollment and assessment were conducted from 1 April 2020 to 30 April 2020. Patients were evaluated in the framework of the telepsychiatry visit. All eligible subjects were asked to provide written informed consent after receiving a complete description of the study and they had the opportunity to ask questions. The study was conducted in accordance with the Declaration of Helsinki and approved by the Ethics Committee of Area Vasta Nord-Ovest Toscana (Italy).

Instruments and Assessments

All subjects were assessed by means of the Impact of Event Scale- Revised (IES-r) (26) to investigate PTSS; Generalized Anxiety Disorder 7-Item (GAD-7) (27) to explore anxiety symptoms; the Hamilton Depression Rating Scale (HAM-D) (28) to evaluate depressive symptoms; and Young Mania Rating Scale (YMRS) (29) to examine manic symptoms. We also gathered the socio-demographical and clinical data through a specific datasheet reporting information on the COVID-19 pandemic. Expert psychiatric clinicians (BB, BFM, CA, and MA) performed clinical interviews and ratings, while self-report scales were sent to patients by email, completed, and then sent back immediately after the visit.

The IES-r is a 22-item scale measuring three core features of PTSD (re-experiencing of traumatic events, avoidance, and hyperarousal) and thus items, coded on a 0–4 scale, are divided into three subscales: intrusion, avoidance, and hyperarousal. All items refer to the last week prior to the assessment. The questionnaire has an adequate internal consistency and high test-retest reliability (r = 0.93). The mean score of the items of each subscale determines the subscale score. The IES-r total score is calculated adding the score of each item. A score over 32 represents a cutoff for PTSS (30). In accordance with the aim of the study, the items referred to the traumatic events that the subjects had experienced in the framework of the COVID-19 pandemic.

The GAD-7 is a self-assessment questionnaire used as a tool for screening and measuring the severity of anxious symptoms. Particularly, it investigates the frequency of anxious symptoms in the last 2 weeks using seven items with a score ranging from 0 (never) to 3 (almost every day). In the validation study, the internal consistency of the scale was excellent (alpha = 0.92). Scores over 10 suggest the presence of moderate to severe anxiety symptoms.

The HAM-D is the most widely used clinician administered scale to evaluate the presence and the severity of depressive symptoms. It consists of 21 items, some of which are assessed on scales from 3 to 5 points, with well-defined severity levels. The total score is assessed on the first 17 items, and a score over 17 suggests the presence of moderate–severe depression.

The YMRS is the most widely clinician administered scale used for the assessment of the severity of manic symptoms. The scale is composed by 11 items: four items are graded on a 0–8 scale, while seven items are graded on a 0–4 scale. The score for each item is summed to obtain the YMRS total score and a score over 20 is usually considered a cut-off for a manic episode. Internal consistency of the instrument is good (alpha = 0.72).

Statistical Analysis

Continuous variables were reported as mean ± standard deviation (SD), whereas categorical variables were reported as percentages. All tests were two-tailed and a p-value < 0.05 was considered statistically significant. All statistical analyses were performed using the Statistical Package for Social Science, version 25.0 (SPSS Inc.).

Chi-square test (or Fisher test if appropriate) was computed to compare socio-demographical and clinical characteristics between individuals with and without PTSS. We computed the non-parametric Mann-Whitney test for the comparisons between subjects with PTSS and those without PTSS of the not normal distributed variables GAD-7, HAM-D, and YMRS scores.

A multiple logistic regression model was utilized to study the strongest predictor of PTSS (dependent variable) among the predictors associated with PTSS in the univariate analysis. Accordingly, gender, work, or social difficulties due to the lockdown, GAD-7, HAM-D, and YMRS total scores were used as independent variables.

Results

The sample included 36 (36%) males and 64 females (64%). The mean age was 47.04 ± 16.18 (min 19, max 81, median 48). Thirty-eight subjects (38%) were married or cohabiting, 23 (23%) lived alone, 17 (17%) had a University degree, and 48 (48%) were employed. Furthermore, 80 (80%) had a psychiatric family history, 23 (23%) reported a comorbid DSM-5 anxiety disorder, and 6 (6%) a DSM-5 obsessive-compulsive disorder. For what concerned the psychopharmacological treatment: 78 (78%) were on antidepressants, 88 (88%) mood stabilizers, 58 (58%) antipsychotics, and 23 (23%) benzodiazepines.

In the framework of the COVID-19 pandemic, 31 subjects (31%) reported to be at risk for medical complications in the case of the COVID-19 infection, one (1%) was positive to COVID-19, and 27 (27%) reported work and economic difficulties due to the lockdown. Moreover, 32 individuals (32%) had a close one at risk of the COVID-19 infection, 8 (8%) a relative or a close one infected by COVID-19, and 3 (3%) a loss of a relative or a close one by COVID-19. Socio-demographical and clinical characteristics of the sample are summarized in Table 1.

TABLE 1
www.frontiersin.org

Table 1. Socio-demographical and clinical characteristics in the total sample (N = 100), patients with (N = 17) and without (N = 83) acute PTSS.

In the total sample the IES-r total score was 18.15 ± 13.67, while the intrusion, avoidance, and hyperarousal subscales scores were 0.81 ± 0.68, 0.77 ± 0.70, and 0.91 ± 0.68, respectively. Seventeen subjects (17%) reported PTSS. Particularly, PTSS was significantly higher in females than in males [15 (23.4%) vs. 2 (5.6%), p = 0.045] and in patients who reported work or financial difficulties due to the lockdown with respect to those who didn't experienced it [10 (37.0%) vs. 7 (9.6%), p = 0.002]. The mean (±SD) GAD-7, HAM-D, and YMRS scores were 6.93 ± 4.73, 10.40 ± 6.42, and 2.58 ± 3.44, respectively. Subjects with PTSS showed significant higher GAD-7 (6.01 ± 3.99 vs. 11.41 ± 5.57, p < 0.001) and HAMD (9.36 ± 5.89 vs. 15.47 ± 6.66, p < 0.001) scores with respect to those without PTSS. Twenty-six (26%) subjects showed moderate to severe anxiety symptoms, 10 (58.8%) with PTSS and 16 (19.3%) without PTSS (p = 0.002). Moderate/severe depressive symptoms were reported by 17 (17%) subjects, 7 (41.2%) with PTSS and 10 (12.0%) without PTSS (p = 0.008). No subjects reported a manic episode (see Table 2 for details).

TABLE 2
www.frontiersin.org

Table 2. Comparison of GAD-7, HAM-D, and YMRS total scores between subjects with (N = 17) and without (N = 83) acute PTSS.

In a logistic regression model, considering gender and work and economic difficulties, besides the GAD-7, HAM-D, and YMRS scores as independent variables, and the PTSS as the dependent variables, the work and economic difficulties [b = 1.641 (SE = 0.757), p = 0.030], the GAD-7 [b = 0.233 (SE = 0.110), p = 0.034], and YMRS [b = −0.301 (SE = 0.143), p = 0.036] total scores showed a statistically significant association with the PTSS. See Table 3.

TABLE 3
www.frontiersin.org

Table 3. Logistic regression model: Gender, work, or economic difficulties GAD-7 score, HAM-D score, and YMRS score as predictive variables associated with acute PTSS in the total sample (N = 100).

Discussion

The present study first explored the onset of acute PTSS, anxiety, and depressive symptoms in a sample of 100 patients with BD evaluated in the framework of a telemedicine service set up in the acute phase of the COVID-19 pandemic in Italy, during the period of national lockdown and ongoing social distancing measures. Seventeen patients reported PTSS, while 26 showed moderate to severe anxiety symptoms and 17 moderate to severe depressive symptoms. Work and financial difficulties, besides anxiety symptoms, appeared to be positively associated with the development of PTSS. Interestingly, acute manic symptoms seemed to be protective.

In the present study, PTSS rates were lower than those found in the majority of previous studies on patients with BD (9, 10). This difference may be related to several factors, such as the unique nature of the traumatic event “pandemic,” the assessment of PTSS in the framework of the acute phase of the pandemic threat, or the euthymic state of the patients at the beginning of the lockdown phase. Nevertheless, these rates appear to be worth clinical attention, considering that PTSS was associated with increased clinical severity of the BD, suicidal behaviors, and worsened quality of life (9, 31, 32). Further, the continuous support and the monitoring provided to the subjects by the tele-psychiatric service might be useful in preventing or attenuating the development of such PTSS (33, 34). As we expected, female patients showed higher PTSS rates than male ones. This result is in line with recent studies on the COVID-19 emergency, reporting greater PTSD rates among females (35). It is well-recognized that female gender is associated with greater vulnerability to development of pathological reactions following traumatic or stressful events, both in the general population (36, 37) and in individuals with BD (9, 38). Interestingly, work and financial problems appear to be strictly associated with PTSS symptom severity. Several authors highlighted the relationship between unemployment or financial difficulties and poor mental health outcomes, such as depression, anxiety, or suicide behaviors (3941). Elbogen et al. (42), in a sample of 1,388 Iraq and Afghanistan War Veterans, found that subjects with poor money incomes were significantly more likely to be affected by PTSD and to report a wide range of reckless, impulsive, or self-destructive behaviors. The impact of low economic status on the development of acute PTSS or PTSD was also reported after traumatic injury (43) or mass trauma (44). Furthermore, PTSS per se can affect global functioning levels, work abilities, and consequently the socioeconomic status (42, 45). In this vicious cycle, the results of the present study highlight the relevance of early detection and treatment of PTSS and PTSD, also in consideration of the possible economic implications in the long-term of the COVID-19 pandemic not yet overcome.

In regard to the other psychopathological features of the sample, we observed substantial percentages of anxiety and depressive symptoms, especially in patients reporting PTSS. High rates of depression and anxiety emerged in several different populations during the COVID-19 pandemic (46, 46, 47) and our data corroborated the assumption that they represented, together with PTSS, the most common psychopathological reactions to the outbreak. Furthermore, the greater depressive and anxiety symptoms burden among subjects with PTSS is so well-recognized in literature that a lively debate is ongoing on the boundaries between these disorders (37, 48). We also found low rates of manic symptoms in the sample during the acute phase of the pandemic. However, to the best of our knowledge, there is still a lack of data on this topic, so it is not easy to compare our results. Previous studies explored depressive or manic reactions related to other categories of traumatic or stressful events. However, these studies focused not on the acute phase but later on in the aftermath of a traumatic event. Particularly, some authors pointed out that in patients with BD, negative life events, such as job loss, bereavement, or personal issues, could worsen not only depressive symptoms but also manic ones (31, 49, 50). In the present study, the quarantine and social-distancing measures related to the COVID-19 pandemic showed to be less likely related to a manic-hypomanic episode, and a possible interpretation of this result could suggest an effective role of tele-psychiatry monitoring, and the consequent treatment changes, in preventing or alleviating manic manifestations.

Surprisingly, the presence of manic symptoms appeared also to be protective for the development of PTSS. This result is in contrast with existent literature on the role of manic/hypomanic state during a traumatic event as a vulnerability factor for the subsequent onset of PTSD symptoms (5154). Nevertheless, it is worth noticing that manic symptoms levels in the present study were low, with no patient reaching the threshold for manic episode. Furthermore, the relationship between the presence of these symptoms and the development of future PTSD cannot be determined with our data and needs to be further assessed. Conversely, in the regression analysis financial difficulties and anxiety symptoms were associated with PTSS. In particular, a great amount of research reported that anxiety, fear, and distress at the time of the trauma were strictly associated with the development of post-traumatic stress reactions (55). Comorbid anxiety was related to an increased risk of PTSD onset both in general population and in longitudinal studies on BD patients (51, 52, 56). Our results corroborate these previous findings in a bipolar sample exposed to the “COVID-19 outbreak” event.

Some limitations should be kept in mind when interpreting the results of the study. The first limitation was the small sample size. However, we may argue that it represented the first homogeneous sample of subjects with BD followed in a telemedicine service during the COVID-19 pandemic. Second, we took advantage of self-report instruments to detect PTSS and anxiety that could be considered less accurate than a clinician assessment. Third, not all possible confounders and relevant COVID-19 related stressors were considered, and thus further studies may be warranted. Finally, the lack of a control group not followed in tele-psychiatry did not allow us to investigate the efficacy of this methodology beyond speculation. However, evaluation of efficacy was not an aim of the study.

In conclusion, the stress related to the acute phase COVID-19 outbreak could lead patients with a severe psychiatric disorder, such as BD, to develop psychopathological reactions such as depression, anxiety, and PTSS. Our results suggest that females who experienced work or financial difficulties may need greater attention in order to prevent possible PTSS. Further studies are needed to assess the psychopathological trajectories of patients with BD after the COVID-19 pandemic and the possible therapeutic strategies that could be useful to prevent negative outcomes in this population.

Data Availability Statement

The data supporting the findings of the article are not publicly available, but it can be provided by the corresponding author on reasonable request.

Ethics Statement

The studies involving human participants were reviewed and approved by Comitato Etico Regionale per la Sperimentazione Clinica della Regione Toscana AREA VASTA NORD OVEST (CEAVNO, Pisa, Italy). The patients/participants provided their written informed consent to participate in this study.

Author Contributions

All authors gave substantial contribution to the study and approved the final version of the manuscript and the manuscript submission to Frontiers in Psychiatry.

Conflict of Interest

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

References

1. Cerami C, Santi GC, Galandra C, Dodich A, Cappa SF, Vecchi T, et al. Covid-19 outbreak in Italy: are we ready for the psychosocial and the economic crisis? Baseline findings from the PsyCovid study. Front Psychiatry. (2020) 11:556. doi: 10.3389/fpsyt.2020.00556

PubMed Abstract | CrossRef Full Text | Google Scholar

2. Giallonardo V, Sampogna G, Del Vecchio V, Luciano M, Albert U, Carmassi C, et al. The impact of quarantine and physical distancing following COVID-19 on mental health: study protocol of a multicentric Italian population trial. Front Psychiatry. (2020) 11:533. doi: 10.3389/fpsyt.2020.00533

PubMed Abstract | CrossRef Full Text | Google Scholar

3. Mazza C, Ricci E, Biondi S, Colasanti M, Ferracuti S, Napoli C, et al. A Nationwide survey of psychological distress among Italian people during the COVID-19 pandemic: immediate psychological responses and associated factors. Int J Environ Res Public Health. (2020) 17:E3165. doi: 10.3390/ijerph17093165

PubMed Abstract | CrossRef Full Text | Google Scholar

4. Wang C, Pan R, Wan X, Tan Y, Xu L, Ho CS, et al. Immediate psychological responses and associated factors during the initial stage of the 2019 Corona virus Disease (COVID-19) epidemic among the general population in China. Int J Environ Res Public Health. (2020) 17:E1729. doi: 10.3390/ijerph17051729

PubMed Abstract | CrossRef Full Text | Google Scholar

5. Liu N, Zhang F, Wei C, Jia Y, Shang Z, Sun L, et al. Prevalence and predictors of PTSS during COVID-19 outbreak in China hardest-hit areas: gender differences matter. Psychiatry Res. (2020) 287:112921. doi: 10.1016/j.psychres.2020.112921

PubMed Abstract | CrossRef Full Text | Google Scholar

6. Tang W, Hu T, Hu B, Jin C, Wang G, Xie C, et al. Prevalence and correlates of PTSD and depressive symptoms one month after the outbreak of the COVID-19 epidemic in a sample of home-quarantined Chinese University students. J Affect Disord. (2020) 274:1–7. doi: 10.1016/j.jad.2020.05.009

PubMed Abstract | CrossRef Full Text | Google Scholar

7. Xiong J, Lipsitz O, Nasri F, Lui LMW, Gill H, Phan L, et al. Impact of COVID-19 pandemic on mental health in the general population: a systematic review. J Affect Disord. (2020) 277:55–64. doi: 10.1016/j.jad.2020.08.001

PubMed Abstract | CrossRef Full Text | Google Scholar

8. Sibley CG, Greaves LM, Satherley N, Wilson MS, Overall NC, Lee CHJ, et al. Effects of the COVID-19 pandemic and nationwide lockdown on trust, attitudes toward government, and well-being. Am Psychol. (2020) 75:618–30. doi: 10.1037/amp0000662

PubMed Abstract | CrossRef Full Text | Google Scholar

9. Cerimele JM, Bauer AM, Fortney JC, Bauer MS. Patients with co-occurring bipolar disorder and posttraumatic stress disorder: a rapid review of the literature. J Clin Psychiatr. (2017) 78:e506–14. doi: 10.4088/JCP.16r10897

CrossRef Full Text | Google Scholar

10. Otto MW, Perlman CA, Wernicke R, Reese HE, Bauer MS, Pollack MH. Posttraumatic stress disorder in patients with bipolar disorder: a review of prevalence, correlates, and treatment strategies. Bipolar Disord. (2004) 6:470–9. doi: 10.1111/j.1399-5618.2004.00151.x

PubMed Abstract | CrossRef Full Text | Google Scholar

11. Hao F, Tan W, Jiang L, Zhang L, Zhao X, Zou Y, et al. Do psychiatric patients experience more psychiatric symptoms during COVID-19 pandemic and lockdown? A case-control study with service and research implications for immunopsychiatry. Brain Behav Immun. (2020) 87:100–6. doi: 10.1016/j.bbi.2020.04.069

PubMed Abstract | CrossRef Full Text | Google Scholar

12. Schützwohl M, Mergel E. social participation, inclusion and mental well-being following SARS-CoV-2 related restrictions on going out - a follow-up study from Germany. Psychiatr Prax. (2020) 47:308–18. doi: 10.1055/a-1202-2427

PubMed Abstract | CrossRef Full Text | Google Scholar

13. Kreuzer PM, Baghai TC, Rupprecht R, Wittmann M, Steffling D, Ziereis M, et al. SARS-CoV-2 risk management in clinical psychiatry: a few considerations on how to deal with an unrivaled threat. Front Psychiatry. (2020) 11:550. doi: 10.3389/fpsyt.2020.00550

PubMed Abstract | CrossRef Full Text | Google Scholar

14. Galletly C. Psychiatry in the COVID-19 era. Aust N Z J Psychiatry. (2020) 54:447–8. doi: 10.1177/0004867420920359

PubMed Abstract | CrossRef Full Text | Google Scholar

15. Shinn AK, Viron M. Perspectives on the COVID-19 pandemic and individuals with serious mental illness. J Clin Psychiatry. (2020) 81:20com13412. doi: 10.4088/JCP.20com13412

PubMed Abstract | CrossRef Full Text | Google Scholar

16. Zhou J, Liu L, Xue P, Yang X, Tang X. Mental health response to the COVID-19 outbreak in China. Am J Psychiatry. (2020) 77:574–5. doi: 10.1176/appi.ajp.2020.20030304

PubMed Abstract | CrossRef Full Text | Google Scholar

17. Kesner L, Horáček J. Three challenges that the COVID-19 pandemic represents for psychiatry. Br J Psychiatry. (2020) 15:1–5. doi: 10.1192/bjp.2020.106

PubMed Abstract | CrossRef Full Text | Google Scholar

18. Figueroa CA, Aguilera A. The need for a mental health technology revolution in the COVID-19 pandemic. Front Psychiatry. (2020) 11:523. doi: 10.3389/fpsyt.2020.00523

PubMed Abstract | CrossRef Full Text | Google Scholar

19. Stoll J, Sadler JZ, Trachsel M. The ethical use of telepsychiatry in the Covid-19 pandemic. Front Psychiatry. (2020) 11:665. doi: 10.3389/fpsyt.2020.00665

PubMed Abstract | CrossRef Full Text | Google Scholar

20. Hilty D, Yellowlees PM, Parrish MB, Chan S. Telepsychiatry: effective, evidence-based, and at a tipping point in health care delivery? Psychiatr Clin North Am. (2015) 38: 559–92. doi: 10.1016/j.psc.2015.05.006

PubMed Abstract | CrossRef Full Text | Google Scholar

21. Corruble E. A viewpoint from Paris on the COVID-19 pandemic: a necessary turn to telepsychiatry. J Clin Psychiatry. (2020) 81:20com13361. doi: 10.4088/JCP.20com13361

PubMed Abstract | CrossRef Full Text | Google Scholar

22. Kavoor AR, Chakravarthy K, John T. Remote consultations in the era of COVID-19 pandemic: preliminary experience in a regional Australian public acute mental health care setting. Asian J Psychiatr. (2020) 51:102074. doi: 10.1016/j.ajp.2020.102074

PubMed Abstract | CrossRef Full Text | Google Scholar

23. Myers US, Birks A, Grubaugh AL, Axon RN. Flattening the curve by getting ahead of it: how the VA healthcare system is leveraging telehealth to provide continued access to care for rural veterans. J Rural Health. (2020) 13:10. doi: 10.1111/jrh.12449

PubMed Abstract | CrossRef Full Text | Google Scholar

24. Starace F, Ferrara M. COVID-19 disease emergency operational instructions for Mental Health Departments issued by the Italian Society of Epidemiological Psychiatry. Epidemiol Psychiatr Sci. (2020) 29:e116. doi: 10.1017/S2045796020000372

PubMed Abstract | CrossRef Full Text | Google Scholar

25. Bojdani E, Rajagopalan A, Chen A, Gearin P, Olcott W, Shankar V, et al. COVID-19 pandemic: impact on psychiatric care in the United States. Psychiatry Res. (2020) 289:113069. doi: 10.1016/j.psychres.2020.113069

CrossRef Full Text | Google Scholar

26. Weiss DS, Marmar CR. The impact of event scale—revised. In: Wilson JP, Keane TM, editors. Assessing Psychological Trauma and PTSD. New York, NY: Guilford Press (1997). p. 399–411. doi: 10.1037/t12199-000

PubMed Abstract | CrossRef Full Text

27. Spitzer RL, Kroenke K, Williams JBW, Löwe B. A brief measure for assessing generalized anxiety disorder: the GAD-7. Arch Intern Med. (2006) 166:1092–7. doi: 10.1001/archinte.166.10.1092

PubMed Abstract | CrossRef Full Text | Google Scholar

28. Hamilton M. Diagnosis and rating scale for depression. Br J Psychiatry. (1960) 3:76–8. doi: 10.1037/t04100-000

PubMed Abstract | CrossRef Full Text

29. Young RC, Biggs JT, Ziegler VE, Meyer DA. A rating scale for mania: reliability, validity and sensitivity. Br J Psychiatry. (1978) 133:429–35. doi: 10.1192/bjp.133.5.429

PubMed Abstract | CrossRef Full Text | Google Scholar

30. Creamer M, Bell R, Falilla S. Psychometric properties of the impact of event scale revised. Behav Res Ther. (2002) 41:1489–96. doi: 10.1016/j.brat.2003.07.010

PubMed Abstract | CrossRef Full Text | Google Scholar

31. Hernandez JM, Cordova MJ, Ruzek J, Reiser R, Gwizdowski IS, Suppes T. Presentation and prevalence of PTSD in a bipolar disorder population: a STEP-BD examination. J Affect Disord. (2013) 150:450–5. doi: 10.1016/j.jad.2013.04.038

PubMed Abstract | CrossRef Full Text | Google Scholar

32. Carmassi C, Bertelloni CA, Dell'Oste V, Foghi C, Diadema E, Cordone A, et al. Post-traumatic stress burden in a sample of hospitalized patients with Bipolar Disorder: which impact on clinical correlates and suicidal risk? J Affect Disord. (2020) 262:267–72. doi: 10.1016/j.jad.2019.10.044

PubMed Abstract | CrossRef Full Text | Google Scholar

33. Bolton AJ, Dorstyn DS. Telepsychology for posttraumatic stress disorder: a systematic review. J Telemed Telecare. (2015) 21:254–67. doi: 10.1177/1357633X15571996

PubMed Abstract | CrossRef Full Text | Google Scholar

34. Sunjaya AP, Chris A, Novianti D. Efficacy, patient-doctor relationship, costs and benefits of utilizing telepsychiatry for the management of post-traumatic stress disorder (PTSD): a systematic review. Trends Psychiatry Psychother. (2020) 42:102–10. doi: 10.1590/2237-6089-2019-0024

PubMed Abstract | CrossRef Full Text | Google Scholar

35. Vindegaard N, Eriksen Benros M. COVID-19 pandemic and mental health consequences: systematic review of the current evidence. Brain Behav Immun. (2020) 89:531–42. doi: 10.1016/j.bbi.2020.05.048

PubMed Abstract | CrossRef Full Text | Google Scholar

36. Kessler RC, Aguilar-Gaxiola S, Alonso J, Benjet C, Bromet EJ, Cardoso G, et al. Trauma and PTSD in the WHO World Mental Health Surveys. Eur J Psychotraumatol. (2017) 8(suppl. 5):1353383. doi: 10.1080/20008198.2017.1353383

PubMed Abstract | CrossRef Full Text | Google Scholar

37. Carmassi C, Dell'Osso L, Manni C, Candini V, Dagani J, Iozzino L, et al. Frequency of trauma exposure and post-traumatic stress disorder in Italy: analysis from the World Mental Health Survey Initiative. J Psychiatr Res. (2014) 59:77–84. doi: 10.1016/j.jpsychires.2014.09.006

PubMed Abstract | CrossRef Full Text | Google Scholar

38. Baldassano CF, Marangell LB, Gyulai L, Ghaemi SN, Joffe H, Kim DR, et al. Gender differences in bipolar disorder: retrospective data from the first 500 STEP-BD participants. Bipolar Disord. (2005) 7:465–70. doi: 10.1111/j.1399-5618.2005.00237.x

PubMed Abstract | CrossRef Full Text | Google Scholar

39. Fiori F, Rinesi F, Spizzichino D, Di Giorgio G. Employment insecurity and mental health during the economic recession: an analysis of the young adult labour force in Italy. Soc Sci Med. (2016) 153:90–8. doi: 10.1016/j.socscimed.2016.02.010

PubMed Abstract | CrossRef Full Text | Google Scholar

40. Paul KI, Geithner E, Moser K. Latent deprivation among people who are employed, unemployed, or out of the labor force. J Psychol. (2009) 143:477–91. doi: 10.3200/JRL.143.5.477-491

CrossRef Full Text | Google Scholar

41. McCloud T, Bann D. Financial stress and mental health among higher education students in the UK up to 2018: rapid review of evidence. J Epidemiol Community Health. (2019) 73:977–84. doi: 10.1136/jech-2019-212154

PubMed Abstract | CrossRef Full Text | Google Scholar

42. Elbogen EB, Johnson SC, Wagner HR, Newton VM, Beckham JC. Financial well-being and postdeployment adjustment among Iraq and Afghanistan war veterans. Mil Med. (2012) 177:669–75. doi: 10.7205/MILMED-D-11-00388

PubMed Abstract | CrossRef Full Text | Google Scholar

43. Visser E, Gosens T, Den Oudsten BL, De Vries J. The course, prediction, and treatment of acute and posttraumatic stress in trauma patients: a systematic review. J Trauma Acute Care Surg. (2017) 82:1158–83. doi: 10.1097/TA.0000000000001447

PubMed Abstract | CrossRef Full Text | Google Scholar

44. Rivière S, Schwoebel V, Lapierre-Duval K, Guinard A, Gardette V, Lang T. Predictors of symptoms of post-traumatic stress disorder after the AZF chemical factory explosion on 21 September 2001, in Toulouse, France. J Epidemiol Community Health. (2008) 62:455–60. doi: 10.1136/jech.2006.057273

PubMed Abstract | CrossRef Full Text | Google Scholar

45. Dell'Osso L, Carmassi C, Consoli G, Conversano C, Ramacciotti CE, Musetti L, et al. Lifetime post-traumatic stress symptoms are related to the health-related quality of life and severity of pain/fatigue in patients with fibromyalgia. Clin Exp Rheumatol. (2011) 29:S73–8.

PubMed Abstract | Google Scholar

46. Liu J, Zhu Q, Fan W, Makamure J, Zheng C, Wang J. Online mental health survey in a medical college in China during the COVID-19 outbreak. Front Psychiatry. (2020) 11:459. doi: 10.3389/fpsyt.2020.00845

CrossRef Full Text | Google Scholar

47. Zhu J, Sun L, Zhang L, Wang H, Fan A, Yang B, et al. Prevalence and influencing factors of anxiety and depression symptoms in the first-line medical staff fighting against COVID-19 in Gansu. Front Psychiatry. (2020) 11:386. doi: 10.3389/fpsyt.2020.00386

PubMed Abstract | CrossRef Full Text | Google Scholar

48. Carmassi C, Bertelloni CA, Cordone A, Cappelli A, Massimetti E, Dell'Oste V, et al. Exploring mood symptom overlap in PTSD diagnosis: ICD-11 and DSM-5 criteria compared in a sample of subjects with Bipolar Disorder. J Affect Disorder. (2020) 276:205–211. doi: 10.1016/j.jad.2020.06.056

PubMed Abstract | CrossRef Full Text | Google Scholar

49. Aldinger F, Schulze TG. Environmental factors, life events, and trauma in the course of bipolar disorder. Psychiatry Clin Neurosci. (2017) 71:6–17. doi: 10.1111/pcn.12433

PubMed Abstract | CrossRef Full Text | Google Scholar

50. Christensen EM, Gjerris A, Larsen JK, Bendtsen BB, Larsen BH, Rolff H, et al. Life events and onset of a new phase in bipolar affective disorder. Bipolar Disord. (2003) 5:356–61. doi: 10.1034/j.1399-5618.2003.00049.x

PubMed Abstract | CrossRef Full Text | Google Scholar

51. Simon NM, Otto MW, Wisniewski SR, Fossey M, Sagduyu K, Frank E, et al. Anxiety disorder comorbidity in bipolar disorder patients: data from the first 500 participants in the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD). Am J Psychiatry. (2004) 161:2222–9. doi: 10.1176/appi.ajp.161.12.2222

PubMed Abstract | CrossRef Full Text | Google Scholar

52. Pollack MH, Simon NM, Fagiolini A, Pitman R, McNally RJ, Nierenberg AA, et al. Persistent posttraumatic stress disorder following September 11 in patients with bipolar disorder. J Clin Psychiatry. (2006) 67:394–9. doi: 10.4088/JCP.v67n0309

PubMed Abstract | CrossRef Full Text | Google Scholar

53. Dell'Osso L, Carmassi C, Rucci P, Ciapparelli A, Conversano C, Marazziti D. Complicated grief and suicidality: the impact of subthreshold mood symptoms. CNS Spectr. (2011) 16:1–6. doi: 10.1017/S1092852912000090

PubMed Abstract | CrossRef Full Text | Google Scholar

54. Dell'osso L, Stratta P, Conversano C, Massimetti E, Akiskal KK, Akiskal HS, et al. Lifetime mania is related to post-traumatic stress symptoms in high school students exposed to the 2009 L'Aquila earthquake. Compr Psychiatry. (2014) 55:357–62. doi: 10.1016/j.comppsych.2013.08.017

PubMed Abstract | CrossRef Full Text | Google Scholar

55. Vance MC, Kovachy B, Dong M, Bui E. Peritraumatic distress: a review and synthesis of 15 years of research. J Clin Psychol. (2018) 74:1457–84. doi: 10.1002/jclp.22612

PubMed Abstract | CrossRef Full Text | Google Scholar

56. Kessler RC, Sonnega A, Bromet E, Hughes M, Nelson CB. Posttraumatic stress disorder in the National Comorbidity Survey. Arch Gen Psychiatry. (1995) 52:1048–60. doi: 10.1001/archpsyc.1995.03950240066012

CrossRef Full Text | Google Scholar

Keywords: tele-psychiatry, post-traumatic stress symptoms, COVID-19, bipolar disorder, mood disorder, pandemic

Citation: Carmassi C, Bertelloni CA, Dell'Oste V, Barberi FM, Maglio A, Buccianelli B, Cordone A and Dell'Osso L (2020) Tele-Psychiatry Assessment of Post-traumatic Stress Symptoms in 100 Patients With Bipolar Disorder During the COVID-19 Pandemic Social-Distancing Measures in Italy. Front. Psychiatry 11:580736. doi: 10.3389/fpsyt.2020.580736

Received: 06 July 2020; Accepted: 03 November 2020;
Published: 03 December 2020.

Edited by:

Andreas Maercker, University of Zurich, Switzerland

Reviewed by:

Matthias Schützwohl, Technische Universität Dresden, Germany
Annett Lotzin, University Medical Center Hamburg-Eppendorf, Germany

Copyright © 2020 Carmassi, Bertelloni, Dell'Oste, Barberi, Maglio, Buccianelli, Cordone and Dell'Osso. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Carlo Antonio Bertelloni, carlo.ab@hotmail.it

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.